COVID-19 and Monkeypox: Epidemiological Update for the Île-de-France Region as of November 10, 2022

Key Points

COVID-19

  • In S44 in Île-de-France, hospital indicators continued to decline.

  • Virological indicators are not available due to the suspension by certain private laboratories of the transmission of COVID-19 test results to SI-DEP.

  • The BA.5 sublineage of the Omicron variant accounted for nearly all sequencing results.

  • Use of primary care and emergency services for “suspected COVID-19” was decreasing.

  • The number of new hospitalizations, the number of new critical care admissions, and the number of COVID-19-related hospital deaths were decreasing.

  • The total number of new COVID-19 cases reported by ESMS was decreasing.

Monkeypox

  • From mid-May through November 7, 2022, 2,498 confirmed cases of monkeypox were recorded in Île-de-France (region of residence), an increase of 1 case compared to the previous week.

In relation to

Our latest news

news

Seniors, pregnant women, and nursing home staff: What is the status of their...

news

Winter Illnesses: A Dynamic and Accessible Way to Track the Spread of...

news

SIBCA 2026: The UrBaCS network presents its solutions for cities and...